Faculty

Charles E. Argoff, MD
Professor of Neurology
Albany Medical College
Director, Comprehensive Pain Center
Albany Medical Center
Albany, New York

Grace Forde, MD
Director of Neurologic Services
Franklin Hospital
North Shore University Hospital
Valley Stream, New York

Mark W. Green, MD, FAAN
Professor of Neurology, Anesthesiology, and Rehabilitition Medicine
Director of Headache and Pain Medicine
Icahn School of Medicine at Mt. Sinai
New York, New York

Target Audience

This activity was developed for neurologists, headache specialists, pain specialists, primary care providers (PCPs), nurses, pharmacists, and other clinican participants who care for the large and diverse population of patients who suffer from migraines.

Program Description

The goal of this activity is to highlight new guidelines for diagnosis of migraine headaches and review treatment strategies for specific patient subtypes, particularly those who experience concomitant gastrointestinal distress. At times, gastrointestinal distress can prevent patients from using their acute medications or reduce the efficacy of oral agents, which means that treatment must be tailored to individual patients and presence of symptoms over time. Patient-centered care based on a comprehensive evaluation of migraine attacks, medical history, and patient preferences, along with the importance of routine follow-up, will be discussed in this engaging, case-based Clinical Research Updates™.

Learning Objectives

Upon completion of this activity, participants should be able to:

  1. Discuss potential pathologic mechanisims underlying common migraine manifestations, including headache, vomiting and nausea, aura, and disease progression
  2. Differentially diagnose migraines based on the latest guidelines for headache classification, patient history, and comprehensive evaluations of presenting symptoms
  3. Tailor acute management strategies to reflect migraine severity, functional disability, and gastrointestinal symptoms
  4. Educate patients on migraines to improve self-management and appropriate medication use

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians.

Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: 

Instructions for Obtaining Credit

In order to receive credit, participants must complete the preactivity questionnaire, postactivity questionnaire, and program evaluation. Participants must also score at least a 70% on the posttest.

For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com

System Requirements

PC
Microsoft Windows 2000 SE or above.
Flash Player Plugin (v7.0.1.9 or greater)
Internet Explorer (v8.0 or greater), Chrome, or Firefox

MAC
MAC OS 10+
Flash Player Plugin (v7.0.1.9 or greater)
Safari

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosure of Conflicts of Interest

Global requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:

Charles Argoff, MD: Consultant: Acorda, AstraZeneca, Daiichi-Sankyo, Depomed, Insys, Nektar, Pfizer, Purdue Pharma, QRxPharma, Teva Pharmaceuticals, XenoPort Grant/Research: Eli Lilly, Endo, Forest Speakers Bureau: Allergan, Depomed, Janssen, Millenium Laboratories, XenoPort.

Grace Forde, MD, has nothing to disclose.

Mark Green, MD, has nothing to disclose.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

  • Rose O'Connor, PhD Nothing to disclose
  • Ashley Marostica, RN, MSN Nothing to disclose
  • Amanda Glazar, PhD Nothing to disclose
  • Andrea Funk Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration (FDA). Global Education Group (Global) and Integritas Communications do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Begin Activity